CrossrefInfokarte
Use of Disease-modifying Therapy in Metabolic Dysfunction-associated Steatohepatitis: Benefits to Trump Challenges
Chronicle of Diabetes Research and Practice · 2026
DOI: 10.4103/cdrp.cdrp_25_25 ↗Abstract
Kein Abstract verfügbar.
EUVIMED